Shareholders snub China Magnesium rights issue

Shareholders have snubbed a $7.8 million China Magnesium rights issue, taking up just 0.3 per cent of the shares offered.
China Magnesium (ASX:CMC) last month launched an ambitious rights issue offering shareholders one new share at 5c for every two shares held — a 92 per cent premium on the previous day’s closing price.
The offer also included a free unlisted option (exercisable at 10c by February 2019) for every new share offered.
China Magnesium shares are trading at about 2.8c – having ranged between 1.4c and 3.3c over the past year.
Eligible shareholders took up 541,522 shares under the rights issue – or 0.3 per cent – raising just $27,076.
China Magnesium thanked shareholders “for their continued support” and said it has already received applications for the $7.475 million shortfall.
The company has been contacted for comment.

- Subscribe to our daily newsletter
- Bookmark this link for small cap news
- Join our small cap Facebook group
- Follow us on Facebook or Twitter
SUBSCRIBE
Get the latest breaking news and stocks straight to your inbox.
It's free. Unsubscribe whenever you want.
By proceeding, you confirm you understand that we handle personal information in accordance with our Privacy Policy.